Scott Olson / Getty Images
Four different Novartis products may contain tablets or caplets from other Novartis products packaged at the company’s Lincoln., Neb. facility.
In addition, the FDA warned Monday some of Novartis' over-the-counter pills may have been packaged with prescription opioid drugs sold by Endo Pharmaceuticals, which are packaged at the same facility. Those drugs include Percocet, Endocet, Opana and Zydone.
The FDA says the risk of finding a wrong tablet among the prescription medications is low.
As for the over-the-counter medications, Novartis has voluntarily recalled all bottle sizes of Excedrin and NoDoz with expiration dates of Dec. 20, 2014 or earlier, as well as Bufferin and Gas-X Prevention products with expiration dates of Dec. 20, 2013 or earlier, in the U.S.
Consumers who have purchased these products should return them to Novartis for a full refund.
Contact the Novartis Consumer Relationship Center at 1-888-477-2403 (available Monday-Friday 9 a.m. to 8 p.m. Eastern Time) for information on how to return the affected products and receive reimbursement.
A full list of the recalled products, below, can also be found on the FDA website:
Bufferin Extra Strength Tablet
Bufferin Low Dose Tablets
Bufferin Regular Strength Tablets
Excedrin Back & Body Caplets
Excedrin Extra Strength Caplets
Excedrin Extra Strength Express Gel Caps
Excedrin Extra Strength Gel Tablets
Excedrin Extra Strength Tablets
Excedrin Migraine Express Gel Caplets
Excedrin Migraine Caplets
Excedrin Migraine Gel Tablets
Excedrin Migraine Tablets
Excedrin PM Caplets
Excedrin PM Express Gel Caplet
Excedrin PM Tablets
Excedrin Sinus Headache Caplets
Excedrin Tension Headache Caplets
Excedrin Tension Headache Express Gel Caplets
Excedrin Tension Headache Gel Tablets
Gas-X Prevention Caplets
NoDoz Maximum Strength Caplets